Stock Alert: Ascendis Pharma A/S (ASND) Trades 3.89% Higher May 13

Equities Staff  |

Ascendis Pharma A/S - ADR (NASDAQ:ASND) stock was among today's market movers, concluding trading higher 3.89% to $83.12 on May 13.

1,169,573 shares traded today compared to the 30-day daily average of 706,172 shares.

The company's stock has climbed 40.53% so far in 2022.

Ascendis Pharma A/S shares have fluctuated between $61.58 and $178.71 over the past twelve months.

The company anticipates its next earnings on 2022-08-10.

For technical charts, analysis, and more on Ascendis Pharma A/S visit the company profile.

About Ascendis Pharma A/S - ADR

Ascendis Pharma is applying its innovative TransCon technologies to build a leading, fully integrated biopharmaceutical company focused on making a meaningful difference in patients' lives. Guided by its core values of patients, science and passion, the company utilizes its TransCon technologies to create new and potentially best-in-class therapies.

To get more information on Ascendis Pharma A/S - ADR and to follow the company's latest updates, you can visit the company's profile page here: Ascendis Pharma A/S - ADR's Profile. For more news on the financial markets be sure to visit Equities News. Also, don't forget to sign-up for the Daily Fix to receive the best stories to your inbox 5 days a week.

Sources: Symbol info widget is provided by TradingView based on 15-minute-delayed prices. All other article data is provided by IEX Cloud on 15-minute delayed prices or EOD company info.

Stock price data is provided by IEX Cloud on a 15-minute delayed basis. Chart price data is provided by TradingView on a 15-minute delayed basis.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:

Trending Articles

Cisco Down 12% in Premarket Trading Thursday After Top Line Miss and Lower Forecast
Under Armour CEO Patrik Frisk To Step Down in Surprise Announcement
Target Hits 52-Week Low After Missing Badly on First Quarter Earnings
DLocal Posts Record Q1, Fifth Consecutive 100%+ Revenue Growth Quarter
Another Crypto Winter Wipes Out Billions in Market Value
Inflation + Recession = Recipe for Volatility

Market Movers

Sponsored Financial Content